04253nam 22007335 450 991073146520332120230616163935.03-031-32192-810.1007/978-3-031-32192-4(MiAaPQ)EBC30602000(Au-PeEL)EBL30602000(DE-He213)978-3-031-32192-4(PPN)272266914(CKB)27060369900041(EXLCZ)992706036990004120230616d2023 u| 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierTechnology Transfer Drug Product Manufacturing Process /by Ajay Babu Pazhayattil, Sanjay Sharma, Joe Paul Philip, Michelle Gischewski-Silva, Marzena Ingram1st ed. 2023.Cham :Springer International Publishing :Imprint: Springer,2023.1 online resource (158 pages)AAPS Introductions in the Pharmaceutical Sciences,2522-8358 ;10Print version: Pazhayattil, Ajay Babu Technology Transfer Cham : Springer International Publishing AG,c2023 9783031321917 Chapter 1: Current Status of Technology Transfer -- Chapter 2: Quality by Design (QbD) Process Design -- Chapter 3: Quality Risk Management (QRM) -- Chapter 4: Technology Transfer Process -- Chapter 5: Scaling-Up of Solid Orals: Granulation, Drying, Size Reduction, Blending, Compression, and Coating Technologies -- Chapter 6: Qualification, Continued Process Verification, and Lifecycle Management -- Chapter 7: Continuous Improvement Case Study: Transforming Legacy Products.Currently, there are no textbooks on drug product manufacturing technology transfer that incorporate the latest regulatory expectations. Recent guidance from regulatory bodies such as the US FDA, EMEA, WHO, and PIC/S has adopted the ICH Lifecycle approach harmonizing concepts across regulatory guidance. This allows organizations to align their technology transfer activities for all regulated markets. However, there is a need for consensus and direction in approaching technology transfer, particularly in understanding how to manage the scale-up effects to ensure regulatory compliance. This textbook offers technology transfer solutions and guidance to the pharmaceutical industry. The chapters provide a systematic understanding of applying the technology transfer concepts in pharmaceutical manufacturing, promoting standardization within the industry. Since Stage 1b is not specified in detail within the regulations, pharmaceutical organizations are left to determine the requirements of the stage. The need to justify the methodologies and utilization of sound science makes it more demanding. The textbook’s authors provide innovative solutions for technology transfer challenges, making it a comprehensive reference document. The approaches can be applied to both small-molecule and large-molecule drug product manufacturing segments, addressing the unmet needs of the industry.AAPS Introductions in the Pharmaceutical Sciences,2522-8358 ;10PharmacyPharmaceutical chemistryPharmacologyDrug delivery systemsPharmacovigilancePharmacyPharmaceuticsPharmacologyDrug DeliveryDrug Safety and PharmacovigilancePharmacy.Pharmaceutical chemistry.Pharmacology.Drug delivery systems.Pharmacovigilance.Pharmacy.Pharmaceutics.Pharmacology.Drug Delivery.Drug Safety and Pharmacovigilance.615.1615.19Pazhayattil Ajay Babu1057742Sharma Sanjay882232Philip Joe Paul1369119Gischewski-Silva Michelle1369120Ingram Marzena1369121MiAaPQMiAaPQMiAaPQBOOK9910731465203321Technology Transfer3395214UNINA